Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimer’s disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study

Izuru Miyoshi, Yoko Fujimoto, Masahito Yamada, Sadahiro Abe, Qinying Zhao, Carol Cronenberger, Kanae Togo, Taro Ishibashi, Martin M. Bednar, James W. Kupiec, Brendon Binneman
  • International Journal of Clinical Pharmacology and Therapeutics, December 2013, Dustri-Verlgag Dr. Karl Feistle
  • DOI: 10.5414/cp201816
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Dr Martin M Bednar